MasakaneI., TsubakiharaY., AkibaT., WatanabeY., IsekiK.The most recent trends of peritoneal dialysis in Japan.Perit Dial Int2008; 28(Suppl 3): S27–31.
2.
KawanishiH., HashimotoY., NakamotoH., NakayamaM., TranæusA.Combination therapy with peritoneal dialysis and hemodialysis.Perit Dial Int2006; 26: 150–4.
3.
KawanishiH., MoriishiM.Clinical effects of combined therapy with peritoneal dialysis and hemodialysis.Perit Dial Int2007; 27(Suppl 2): S126–9.
4.
SilaruksS., SirivongsD., ChunlertrithD.Left ventricular hypertrophy and clinical outcome in CAPD patients.Perit Dial Int2000; 20: 461–6.
5.
LangR.M., BierigM., DevereuxR.B., FlachskampfF.A., FosterE., PellikkaP.A.Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.J Am Soc Echocardiogr2005; 18: 1440–63.
6.
WangA.Y., LaiK.N.The importance of residual renal function in dialysis patients.Kidney Int2006; 69: 1726–32.
7.
LondonG.M., PannierB., GuerinA.P., BlacherJ., MarchaisS.J., DarneB.Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study.J Am Soc Nephrol2001; 12: 2759–67.
